Expert Opinion on Drug Discovery, Volume 11, Issue 11 (2016)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Drug Discovery, Volume 11, Issue 11 (2016)

See all volumes and issues
Vol 19, 2024 Vol 18, 2023 Vol 17, 2022 Vol 16, 2021 Vol 15, 2020 Vol 14, 2019 Vol 13, 2018 Vol 12, 2017 Volume 11, 2016 Vol 10, 2015 Vol 9, 2014 Vol 8, 2013 Vol 7, 2012 Vol 6, 2011 Vol 5, 2010 Vol 4, 2009 Vol 3, 2008 Vol 2, 2007 Vol 1, 2006
Download citations Download PDFs Download issue

Leukemia and Lymphoma Drug Discovery

Foreword

Introduction
Foreword
David Grech
Page: 1027
Published online: 08 Oct 2016
CitationforForeword | Full Text | References | PDF (92 KB)
  • 782 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Editorial

Editorial
The application of mass spectrometry to leukemia drug discovery
Gail J. Roboz & John Roboz
Pages: 1029-1032
Published online: 23 Sep 2016
First Page PreviewforThe application of mass spectrometry to leukemia drug discovery | Full Text | References | PDF (460.2 KB)
  • 1265 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access

Review

Review
Innovation in non-Hodgkin lymphoma drug discovery: what needs to be done?
Magdalena Witkowska, Piotr Smolewski, Agata Majchrzak & Tadeusz Robak
Pages: 1033-1045
Published online: 07 Sep 2016
AbstractforInnovation in non-Hodgkin lymphoma drug discovery: what needs to be done? | Full Text | References | PDF (1.1 MB)
  • 243 Views
  • 1 CrossRef citations
  • 0Altmetric
Review
Toll-like receptors targeting technology for the treatment of lymphoma
Maria Batool, Muhammad Ayaz Anwar & Sangdun Choi
Pages: 1047-1059
Published online: 19 Sep 2016
AbstractforToll-like receptors targeting technology for the treatment of lymphoma | Full Text | References | PDF (1.3 MB)
  • 235 Views
  • 5 CrossRef citations
  • 0Altmetric
Review
The development of agents targeting the BCR-ABL tyrosine kinase as Philadelphia chromosome-positive acute lymphoblastic leukemia treatment
Xavier Thomas & Maël Heiblig
Pages: 1061-1070
Published online: 31 Aug 2016
AbstractforThe development of agents targeting the BCR-ABL tyrosine kinase as Philadelphia chromosome-positive acute lymphoblastic leukemia treatment | Full Text | References | PDF (861.2 KB)
  • 277 Views
  • 8 CrossRef citations
  • 0Altmetric
Review
Therapeutic target discovery and drug development in cancer stem cells for leukemia and lymphoma: from bench to the clinic
Angelo B. A. Laranjeira & Sherry X. Yang
Pages: 1071-1080
Published online: 25 Sep 2016
AbstractforTherapeutic target discovery and drug development in cancer stem cells for leukemia and lymphoma: from bench to the clinic | Full Text | References | PDF (969.6 KB)
  • 333 Views
  • 6 CrossRef citations
  • 0Altmetric
Review
Mouse models for pre-clinical drug testing in leukemia
Sanil Bhatia, Svenja Daschkey, Franziska Lang, Arndt Borkhardt & Julia Hauer
Pages: 1081-1091
Published online: 09 Sep 2016
AbstractforMouse models for pre-clinical drug testing in leukemia | Full Text | References | PDF (874.7 KB)
  • 312 Views
  • 6 CrossRef citations
  • 0Altmetric
Review
Drug design strategies focusing on the CXCR4/CXCR7/CXCL12 pathway in leukemia and lymphoma
Federica Barbieri, Adriana Bajetto, Stefano Thellung, Roberto Würth & Tullio Florio
Pages: 1093-1109
Published online: 20 Sep 2016
AbstractforDrug design strategies focusing on the CXCR4/CXCR7/CXCL12 pathway in leukemia and lymphoma | Full Text | References | PDF (2 MB)
  • 775 Views
  • 26 CrossRef citations
  • 0Altmetric
Review
The development of targeted new agents to improve the outcome for children with leukemia
Francisco Bautista, Jasper Van der Lugt, Pamela R. Kearns, Francis J. Mussai, C. Michel Zwaan & Lucas Moreno
Pages: 1111-1122
Published online: 27 Sep 2016
AbstractforThe development of targeted new agents to improve the outcome for children with leukemia | Full Text | References | PDF (1 MB)
  • 308 Views
  • 7 CrossRef citations
  • 0Altmetric

Drug Discovery Case History

Article
The discovery and the development of bendamustine for the treatment of non-Hodgkin lymphoma
Wataru Munakata & Kensei Tobinai
Pages: 1123-1130
Published online: 16 Sep 2016
AbstractforThe discovery and the development of bendamustine for the treatment of non-Hodgkin lymphoma | Full Text | References | PDF (612.7 KB)
  • 453 Views
  • 3 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

On-demand modular assembly for expedited PROTAC development
Ayan Mukherjee et al.
Editorial | Published online: 6 Jun 2024
Free Access
Hydrophobic tagging of small molecules: an overview of the literature and future outlook
Yang Zhou et al.
Review Article | Published online: 2 Jun 2024
Using induced pluripotent stem cells for drug discovery in arrhythmias
Diogo Teles et al.
Review Article | Published online: 2 Jun 2024
Open Access
Inclisiran: the preclinical discovery and development of a novel therapy for the treatment of atherosclerosis
Donatos Tsamoulis et al.
Article | Published online: 28 May 2024
View all latest articles